NIP2-3 Antibody

Shipped with Ice Packs
In Stock

Description

NIP2 (Centrobin) and Associated Antibodies

NIP2 (Nek2-interacting protein 2), also known as centrobin, is a centrosomal protein implicated in microtubule stabilization and mitotic regulation . A polyclonal antibody targeting human NIP2 was generated and validated in immunoblot and immunofluorescence assays, detecting endogenous NIP2 at ~101 kDa .

Key Functional Findings:

  • Microtubule Stabilization: Overexpression of the C-terminal domain (GFP-NIP2 445-903) induced microtubule bundling and resistance to nocodazole-induced depolymerization .

  • RNAi Knockdown Effects: Suppression of NIP2 disrupted microtubule organizing centers (MTOCs), reduced cell size, and impaired microtubule regrowth post-nocodazole treatment .

  • Nek2 Regulation: Nek2 kinase activity inversely correlates with centrosomal NIP2 levels. Nek2 suppression increased centrosomal NIP2, while overexpression reduced it .

Table 1: NIP2 Antibody Applications

ApplicationTarget ValidationFunctional AssayLocalization Study
ImmunoblotDetects 101 kDaCell cycle analysisCentrosome staining
ImmunofluorescenceN/AMicrotubule imagingCytoplasmic aggregates

NIP3 (BNIP3 Homolog) and Antibody Interactions

NIP3 (Nineteen kDa interacting protein-3) is a mitochondrial protein interacting with Bcl-2 family members . Antibody studies using HA-tagged NIP3 variants revealed mitochondrial localization via colocalization with HSP60 .

Key Interaction Data:

  • Self-Association: NIP3 forms homodimers, as shown by yeast two-hybrid assays (Table 2) .

  • Mitochondrial Localization: Full-length NIP3 colocalizes with HSP60, while truncation mutants (e.g., HA-NIP3 163) show diffuse cytoplasmic distribution .

Table 2: Yeast Two-Hybrid Interaction Analysis

Protein Pairβ-Galactosidase Activity (Relative)Interaction Outcome
NIP3/NIP3103.3Strong (Blue)
NIP3/MK0.3None (White)
NIP3/PTP20.5None (White)

Potential Interpretations of "NIP2-3 Antibody"

The designation "NIP2-3" is not standard in scientific literature. Possible explanations include:

  • Nomenclature Variant: A non-canonical reference to isoforms of NIP2 (e.g., splice variants) or a combined target (NIP2 and NIP3).

  • Antibody Clone: Commercial antibodies such as NaPi2b/SLC34A2 (D3V3I) Rabbit mAb (#66445) or anti-centrobin antibodies might be conflated with "NIP2-3."

Research Gaps and Recommendations

  • Target Specificity: No studies directly characterize an antibody targeting both NIP2 and NIP3.

  • Clinical Relevance: Antibodies against NIP2/centrobin are primarily research tools , whereas NIP3 antibodies explore apoptosis pathways .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
NIP2-3; Aquaporin NIP2-3; NOD26-like intrinsic protein 2-3; ZmNIP2-3; ZmNIP2;3
Target Names
NIP2-3
Uniprot No.

Target Background

Function
Aquaporins are membrane proteins that facilitate the transport of water and small neutral solutes across cell membranes.
Database Links

KEGG: zma:542497

STRING: 4577.GRMZM2G081239_P01

UniGene: Zm.623

Protein Families
MIP/aquaporin (TC 1.A.8) family, NIP (TC 1.A.8.12) subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is NIP2-3 and what cellular functions is it associated with?

NIP2-3 belongs to the NOD26-like intrinsic proteins (NIPs) family, which functions as channel proteins involved in water and small solute transport across membranes in plant cells. These proteins are critical for maintaining water homeostasis, nutrient uptake, and stress responses in plants such as maize (Zea mays). The specific cellular functions associated with NIP2-3 include facilitating the transport of water, glycerol, and potentially other small, uncharged solutes. When investigating NIP2-3 functions, researchers should consider both its role in normal physiological conditions and during environmental stress responses, as these channels often play differential roles depending on cellular conditions.

How should validation of NIP2-3 antibody specificity be approached in research applications?

Antibody validation is crucial for reliable research results. For NIP2-3 antibody, a comprehensive validation approach should include:

  • Western blotting with positive and negative controls

  • Immunoprecipitation followed by mass spectrometry

  • Immunofluorescence with subcellular localization analysis

  • Testing across multiple tissue types from Zea mays

Independent third-party testing is strongly recommended, as studies have shown that many commercial antibodies fail to recognize their intended targets or bind to non-target proteins. A 2013 study demonstrated that only 48% of 3,313 antibodies recommended for western blotting actually recognized their intended protein . The use of knockout or knockdown controls is particularly important for validating antibody specificity, as this provides the most stringent confirmation that the antibody is detecting the intended target.

What are the recommended storage and handling conditions for NIP2-3 antibody?

For optimal performance and longevity of the NIP2-3 antibody:

  • Store concentrated antibody aliquots at -20°C or -80°C to prevent freeze-thaw cycles

  • For working solutions, store at 4°C for short-term use (1-2 weeks)

  • Avoid repeated freeze-thaw cycles by preparing single-use aliquots

  • Add protein stabilizers (such as BSA at 1-5%) for diluted solutions

  • When conducting experiments, allow the antibody to reach room temperature before opening the container

  • Check for precipitates and centrifuge if necessary before using

These practices help maintain antibody activity and specificity, which is especially important for plant protein research where target abundance may be lower than in some animal systems.

What are the optimal protocols for using NIP2-3 antibody in different experimental techniques?

The experimental application of NIP2-3 antibody requires technique-specific optimization:

Western Blotting:

  • Recommended dilution: 1:500-1:2000 (optimize for your specific sample)

  • Blocking solution: 5% non-fat milk or 3-5% BSA in TBST

  • Primary antibody incubation: Overnight at 4°C

  • Detection system: HRP-conjugated secondary antibody followed by ECL

  • Consider using gradient gels (10-15%) for optimal separation of plant membrane proteins

Immunohistochemistry/Immunofluorescence:

  • Fixation: 4% paraformaldehyde for 15-20 minutes

  • Antigen retrieval: Citrate buffer (pH 6.0), microwave method

  • Recommended dilution: 1:50-1:200

  • Incubation time: 1-2 hours at room temperature or overnight at 4°C

  • Include controls for autofluorescence, which is common in plant tissues

Immunoprecipitation:

  • Pre-clear lysates with protein A/G beads

  • Antibody amount: 2-5 μg per 500 μg of total protein

  • Incubation: 2-4 hours at 4°C or overnight

  • Use appropriate lysis buffers that preserve membrane protein integrity

Each method requires optimization based on specific experimental conditions and tissue types.

How can cross-reactivity with other NIP family proteins be assessed and controlled?

Cross-reactivity assessment is critical when working with protein families like NIPs that share sequence homology. Recommended approaches include:

  • Sequence alignment analysis: Compare the immunogen sequence of the NIP2-3 antibody with other NIP family proteins to identify potential cross-reactive regions

  • Pre-absorption controls: Pre-incubate the antibody with recombinant NIP2-3 protein before use in experiments to confirm specificity

  • Parallel testing with other NIP antibodies: Compare staining/detection patterns with antibodies against other NIP family members (like NIP2-1, NIP2-2, NIP1-1)

  • Knockout/knockdown validation: Use genetic models where NIP2-3 is absent or suppressed to confirm specificity

  • Western blot analysis with recombinant proteins: Test against purified recombinant versions of different NIP family members

This methodical approach helps ensure that experimental findings are specifically related to NIP2-3 rather than other structurally similar proteins in the same family.

What are the main considerations for using NIP2-3 antibody in different plant tissue types?

When applying NIP2-3 antibody across different plant tissues, researchers should consider:

Tissue-specific expression variations:

  • Root tissues may require different extraction buffers due to higher phenolic compounds

  • Leaf tissues might need additional steps to remove chlorophyll that can interfere with detection

  • Reproductive tissues may have different expression levels requiring adjusted antibody concentrations

Sample preparation considerations:

  • Include protease inhibitors appropriate for plant tissues

  • Consider tissue-specific fixation times for immunohistochemistry

  • Adjust cell lysis conditions based on tissue hardness and composition

Background reduction strategies:

  • Pre-incubation with non-immune serum from the same species as the secondary antibody

  • Longer blocking times for tissues with high background

  • Use of tissue-specific negative controls

Creating a tissue expression profile using the antibody can help establish baseline detection levels across different plant parts and developmental stages.

How can NIP2-3 antibody be used to investigate drought and salt stress responses in maize?

NIP2-3 antibody can be leveraged to study stress responses through multiple approaches:

Protein expression profiling:

  • Quantitative western blotting to measure NIP2-3 protein levels under different stress conditions

  • Immunohistochemistry to examine changes in tissue-specific localization during stress

  • Flow cytometry of protoplasts to quantify expression changes at the single-cell level

Protein interaction studies:

  • Co-immunoprecipitation to identify stress-responsive protein partners

  • Proximity ligation assay to detect in situ protein-protein interactions that occur during stress

Experimental design considerations:

  • Include time-course studies (early vs. late response)

  • Compare gradual vs. acute stress application

  • Analyze both aerial tissues and roots separately

  • Include recovery phase after stress removal

Correlating NIP2-3 protein levels with physiological parameters (water potential, osmotic adjustment, photosynthetic rate) provides comprehensive insights into its role during stress conditions.

What methodologies are recommended for quantitative analysis of NIP2-3 protein levels?

For accurate quantification of NIP2-3 protein, consider these methodological approaches:

Western blot quantification:

  • Use internal loading controls specific for plant samples (e.g., actin, tubulin)

  • Implement standard curves using recombinant NIP2-3 protein

  • Employ digital imaging systems rather than film for better dynamic range

  • Validate linearity of signal across your expected concentration range

ELISA development:

  • Sandwich ELISA using purified NIP2-3 protein standards

  • Competitive ELISA for samples with potential interfering compounds

  • Consider developing a custom ELISA if commercial options are unavailable

Mass spectrometry approaches:

  • Selected reaction monitoring (SRM) for absolute quantification

  • Use isotopically labeled peptide standards corresponding to unique NIP2-3 regions

  • Account for extraction efficiency when reporting final concentrations

Regardless of the method chosen, validation across multiple techniques provides the most robust quantification strategy.

How can NIP2-3 antibody be used in conjunction with other research tools to elucidate membrane transport mechanisms?

Integrating NIP2-3 antibody with complementary research tools creates powerful experimental frameworks:

Combination with fluorescent probes:

  • Dual labeling with membrane domain markers to identify microdomains

  • Co-visualization with fluorescent transport substrates (e.g., fluorescent water analogs)

  • FRET studies to examine proximity to other transport proteins

Integration with electrophysiology:

  • Antibody labeling before or after patch-clamp studies

  • Correlation of protein localization with transport activity in the same cells

  • Antibody-mediated inhibition studies to confirm function

Coupling with advanced microscopy:

  • Super-resolution microscopy to visualize nanoscale organization

  • FRAP (Fluorescence Recovery After Photobleaching) to examine dynamics

  • Live cell imaging to track responses to experimental manipulations

Combined genetic and immunological approaches:

  • Analysis in transgenic lines with modified NIP2-3 expression

  • Complementation studies in deletion mutants followed by antibody localization

This integrative approach provides multidimensional data on both the localization and function of NIP2-3 in transport processes.

What are the most common reasons for NIP2-3 antibody failure in experiments and how can they be addressed?

Common causes of antibody failure and their solutions include:

ProblemPossible CausesTroubleshooting Approaches
No signalDegraded antibody, insufficient antigen, inadequate exposureTest antibody on positive control, increase antibody concentration, optimize exposure time
Weak signalSuboptimal antibody concentration, inefficient transfer, poor antigen accessibilityTitrate antibody, optimize transfer conditions, improve antigen retrieval
High backgroundInsufficient blocking, excessive antibody, non-specific bindingIncrease blocking time, dilute antibody, add detergent to wash buffers
Multiple bandsCross-reactivity, protein degradation, post-translational modificationsConfirm with knockout controls, add protease inhibitors, verify with orthogonal methods
Variable resultsInconsistent sample preparation, antibody instabilityStandardize protocols, use fresh aliquots, consider lot-to-lot variation

When troubleshooting, it's advisable to test multiple parameters individually rather than changing several conditions simultaneously. The antibody specificity crisis in research underscores the importance of rigorous validation and controls, as universities in the United States alone waste over $350 million annually on antibodies that don't work as advertised .

How should researchers evaluate batch-to-batch variability in NIP2-3 antibody preparations?

Batch-to-batch variation is a significant concern in antibody research. To address this:

Implement systematic validation protocols:

  • Test each new lot against a reference lot using identical samples

  • Quantify signal intensity, background levels, and band/signal patterns

  • Document lot-specific working dilutions and optimal conditions

Establish internal standards:

  • Maintain a reference sample set to test each new batch

  • Create a standardized scoring system for antibody performance

  • Consider maintaining a "benchmark" lot for critical experiments

Documentation practices:

  • Record lot numbers in all experimental notes and publications

  • Maintain a laboratory database of performance metrics by lot

  • Note any deviations in experimental protocols required for specific lots

Some researchers advocate for recombinant antibodies, which may offer improved batch-to-batch consistency compared to hybridoma or animal-derived antibodies .

What validation techniques can distinguish between true NIP2-3 signal and artifacts in complex plant samples?

Distinguishing specific signals from artifacts requires multiple validation strategies:

Genetic validation approaches:

  • Testing in NIP2-3 knockout/knockdown plants

  • Correlation with overexpression systems

  • Analysis in related plant species with varying NIP2-3 homology

Technical validation:

  • Peptide competition assays to block specific binding

  • Multiple antibodies targeting different NIP2-3 epitopes

  • Comparing detection methods (fluorescence vs. chromogenic)

  • Pre-adsorption controls with recombinant protein

Signal authentication tests:

  • Subcellular fractionation to confirm expected localization

  • Correlation of signal with mRNA expression (in situ hybridization)

  • Orthogonal detection methods (mass spectrometry identification of immunoprecipitated proteins)

The validation approaches should be tailored to the specific experimental technique and reported transparently in publications to address the widely recognized issues with antibody reproducibility in research .

How can epitope mapping improve experimental design when working with NIP2-3 antibody?

Understanding the specific epitope recognized by the NIP2-3 antibody provides significant experimental advantages:

Benefits of epitope mapping:

  • Predicts accessibility in different applications (native vs. denatured conditions)

  • Identifies potential cross-reactivity with homologous proteins

  • Informs appropriate sample preparation methods

  • Guides interpretation of negative results (epitope masking vs. absence of protein)

Epitope mapping approaches:

  • Overlapping peptide arrays covering the NIP2-3 sequence

  • Mutagenesis studies with recombinant protein fragments

  • Hydrogen-deuterium exchange mass spectrometry

  • Computational prediction followed by experimental validation

Applying epitope knowledge:

  • For conformational epitopes, use native conditions for immunoprecipitation

  • For buried epitopes, ensure proper denaturation in western blotting

  • For epitopes in conserved regions, implement additional specificity controls

  • For epitopes near post-translational modification sites, consider how modifications might affect detection

Knowledge of the specific epitope recognized by the antibody enables more precise experimental design and more reliable interpretation of results.

What are the considerations for using NIP2-3 antibody in multi-species comparative studies?

When extending NIP2-3 antibody use beyond Zea mays to other plant species:

Sequence homology assessment:

  • Perform sequence alignments of the epitope region across target species

  • Predict potential cross-reactivity based on amino acid conservation

  • Consider evolutionary relationships between species of interest

Validation requirements:

  • Confirm specificity in each new species independently

  • Use species-specific positive and negative controls

  • Validate with complementary techniques (e.g., mass spectrometry)

Experimental adjustments:

  • Optimize antibody concentration for each species

  • Adjust incubation conditions based on anticipated affinity differences

  • Consider species-specific sample preparation modifications

Data interpretation:

  • Account for potential differences in epitope accessibility

  • Consider evolutionary changes in protein function across species

  • Document species-specific binding characteristics

Multi-species studies require more extensive validation but can provide valuable evolutionary insights into NIP protein conservation and diversification.

How can NIP2-3 antibody be integrated into studies of protein-protein interactions and protein complexes?

NIP2-3 antibody can be leveraged for studying interaction networks through several sophisticated approaches:

Co-immunoprecipitation strategies:

  • Standard co-IP followed by western blotting for known interactors

  • Co-IP coupled with mass spectrometry for unbiased interaction discovery

  • Sequential co-IP to isolate specific subcomplexes

  • Crosslinking before co-IP to capture transient interactions

Proximity-based methods:

  • Proximity ligation assay (PLA) for in situ detection of interactions

  • BioID or APEX2 proximity labeling combined with antibody validation

  • FRET or BRET analysis with antibody-based confirmation

Native complex analysis:

  • Blue native PAGE followed by western blotting

  • Size exclusion chromatography with fraction immunoblotting

  • Sucrose gradient ultracentrifugation with fraction analysis

Visualization of complexes:

  • Immunoelectron microscopy for ultrastructural localization

  • Super-resolution co-localization studies

  • Array tomography for 3D reconstruction of protein complexes

These approaches can reveal how NIP2-3 functions within larger molecular assemblies and identify novel interaction partners that may regulate its activity or localization.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.